QLINE
QLINE financials
- Market cap
- ₹1.6k Cr
- Sector
- Healthcare
- Calls analysed
- 1
QLINE Q4 FY26
What went well
- Consolidated revenue from operations increased to INR341.7 crores in FY26, representing a growth of approximately 9% over FY25.
- Gross profit increased by 24% year-on-year to INR207.6 crores, with gross margin expanding significantly from 53.3% in FY25 to 60.8% in FY26 (750 bps improvement).
- EBITDA increased by 39% to INR98.1 crores in FY26, with EBITDA margin improving from 22.5% to 28.7%.
What to watch
- H2 FY26 experienced a year-on-year de-growth of about 8.6% in instrument revenue due to the cyclical nature of instrument seeding in FY25.
- Revenue concentration remains high, with 77% from Uttar Pradesh and 65% from the B2G segment.
Guidance record · Q4 FY26
updates from the last two tracked quarters 8 tracked 0 delivered 0 missed 8 open- Consolidated Revenue Growth open said Q4 FY26 Promised: 30% to 35% Q4 FY26: Based on our current business momentum and growth initiative, we are targeting revenue growth of approximately 30% to 35% of FY27
All 8 tracked — see the targets, revisions and supporting evidence.
Open the guidance ledgerQuarterly results
| Line item | Q4 FY25 | Q4 FY26 |
|---|---|---|
| Revenue | 217 | 198 |
| EBITDA | 45 | 62 |
| Net profit | 9 | 34 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +45.7% YTD
YTD: ₹474.6 on 29 May 2026 → ₹691.35. High ₹726.2 (11 Sept 2026), low ₹453.35 (1 Jun 2026).
How the price took the results
close before → close after
- Q4 FY26
- +0.9%
- 23 Jun
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Balance sheet
| Year ending | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹16 Cr |
| Reserves | ₹126 Cr | ₹160 Cr | ₹188 Cr | ₹230 Cr |
| Borrowings | ₹74 Cr | ₹97 Cr | ₹166 Cr | ₹225 Cr |
| Other liabilities | ₹51 Cr | ₹81 Cr | ₹99 Cr | ₹87 Cr |
| Total liabilities | ₹252 Cr | ₹339 Cr | ₹455 Cr | ₹559 Cr |
| Fixed assets | ₹23 Cr | ₹60 Cr | ₹92 Cr | ₹145 Cr |
| Capital work in progress | ₹12 Cr | ₹19 Cr | ₹63 Cr | ₹15 Cr |
| Investments | ₹16 Cr | ₹29 Cr | ₹0 Cr | ₹17 Cr |
| Other assets | ₹201 Cr | ₹232 Cr | ₹301 Cr | ₹381 Cr |
| Total assets | ₹252 Cr | ₹339 Cr | ₹455 Cr | ₹559 Cr |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at May 2026
- Promoters
- 67.5%
- FIIs
- 1.7%
- DIIs
- 10.1%
- Public
- 20.7%
Who is on the register
Named in the May 2026 filing
Every holder of QLINE above SEBI's 1% disclosure line.
| Holder | Stake |
|---|---|
| Saurabh Garg | 43.69% |
| Amita Garg | 16.88% |
| Abhay Agrawal | 3.24% |
| Ajay Kumar Mahanty | 3.21% |
| Vikas Vijaykumar Khemani | 1.87% |
| Abakkus Small Cap Fund Mutual fund | 1.43% |
| Hem Finlease Private Limited- Prop. | 1.34% |
| Market Maker Unclassified | 1.34% |
| Carnelian AIF Category I Trust-Scheme 1 AIF | 1.21% |
| Abakkus Flexi Edge Fund-1 AIF | 1.05% |
| Calliope Capital Advisors Llp | 1.00% |
| Shubham Garg | 0.14% |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse QLINE
Guides on how to read this kind of business and the numbers that matter.